- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Tumor protein p53 (TP53) is a sequence-specific transcription factor that functions as a central tumor suppressor regulating DNA damage responses, apoptosis, and genomic stability. The TP53 Antibody N-Terminus clone rBP53-12 is a recombinant mouse monoclonal antibody developed to recognize the N-terminal region of the p53 protein, enabling detection of the regulatory domain responsible for transcriptional activation and protein interaction signaling.
TP53 antibody reagents are widely used in cancer biology because p53 is one of the most frequently altered proteins in human tumors. The TP53 gene, located on chromosome 17p13.1, encodes Tumor protein p53, also known as Cellular tumor antigen p53. The p53 protein contains several functional regions including an N-terminal transcriptional activation domain, a central DNA-binding domain responsible for sequence-specific transcriptional regulation, a tetramerization domain required for formation of active transcriptional complexes, and a C-terminal regulatory region that modulates DNA binding and protein stability.
The defining feature of the TP53 Antibody N-Terminus clone rBP53-12 is recognition of the N-terminal regulatory region of Tumor protein p53. The N-terminus of p53 contains transcriptional activation domains that recruit transcription factors and co-regulators required for activation of p53-responsive genes. This N-terminal segment is also a key regulatory interface for interaction with proteins such as MDM2, which binds the N-terminus of p53 and mediates ubiquitination and proteasomal degradation under normal cellular conditions.
Because the N-terminal region controls p53 activation and regulatory signaling, antibodies targeting this domain are valuable tools for studying the mechanisms that regulate TP53 stability and transcriptional activity. The TP53 Antibody N-Terminus enables researchers to investigate expression of the N-terminal portion of p53 and to analyze signaling pathways that stabilize the protein following DNA damage, oncogenic stress, or cellular injury.
The recombinant monoclonal clone rBP53-12 therefore provides a defined reagent for detecting the N-terminal domain of Tumor protein p53 in experimental systems investigating tumor suppressor signaling. By targeting the regulatory N-terminal region of TP53, the TP53 Antibody N-Terminus clone rBP53-12 supports research focused on transcriptional activation mechanisms, p53 stabilization pathways, and the molecular control of genomic integrity.
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the TP53 Antibody N-Terminus / p53 N-Terminal Antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human wild-type p53 protein was used as the immunogen for this TP53 Antibody N-Terminus / p53 N-Terminal Antibody. The epitope has been mapped to within amino acids 16-25.
Store the recombinant TP53 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
p53 antibody, TP53 antibody, Tumor protein p53 antibody, Cellular tumor antigen p53 antibody, p53 tumor suppressor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.